Anti-CRMP2/DPYSL2 monoclonal antibody
The Alternative Names of target: CRMP-2,CRMP2,Collapsin response mediator protein 2 (CRMP-2),Crmp2,DHPRP2,DPYSL2,DRP-2,DRP2,Dihydropyrimidinase-related protein 2,Dpysl2,Musunc33,N2A3,TOAD-64,ULIP-2,ULIP2,Ulip2,Unc-33-like phosphoprotein 2 (ULIP-2)
Pre-made anti-CRMP2/DPYSL2 monoclonal antibody (mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research.
Go
to CRMP2/DPYSL2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T92078-Ab-1/ GM-Tg-hg-T92078-Ab-2 | Anti-Human CRMP2/DPYSL2 monoclonal antibody | Human |
GM-Tg-rg-T92078-Ab-1/ GM-Tg-rg-T92078-Ab-2 | Anti-Rat CRMP2/DPYSL2 monoclonal antibody | Rat |
GM-Tg-mg-T92078-Ab-1/ GM-Tg-mg-T92078-Ab-2 | Anti-Mouse CRMP2/DPYSL2 monoclonal antibody | Mouse |
GM-Tg-cynog-T92078-Ab-1/ GM-Tg-cynog-T92078-Ab-2 | Anti-Cynomolgus/Rhesus macaque CRMP2/DPYSL2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T92078-Ab-1/ GM-Tg-felg-T92078-Ab-2 | Anti-Feline CRMP2/DPYSL2 monoclonal antibody | Feline |
GM-Tg-cang-T92078-Ab-1/ GM-Tg-cang-T92078-Ab-2 | Anti-Canine CRMP2/DPYSL2 monoclonal antibody | Canine |
GM-Tg-bovg-T92078-Ab-1/ GM-Tg-bovg-T92078-Ab-2 | Anti-Bovine CRMP2/DPYSL2 monoclonal antibody | Bovine |
GM-Tg-equg-T92078-Ab-1/ GM-Tg-equg-T92078-Ab-2 | Anti-Equine CRMP2/DPYSL2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T92078-Ab-1/ GM-Tg-hg-T92078-Ab-2;
GM-Tg-rg-T92078-Ab-1/ GM-Tg-rg-T92078-Ab-2;
GM-Tg-mg-T92078-Ab-1/ GM-Tg-mg-T92078-Ab-2; GM-Tg-cynog-T92078-Ab-1/ GM-Tg-cynog-T92078-Ab-2; GM-Tg-felg-T92078-Ab-1/ GM-Tg-felg-T92078-Ab-2; GM-Tg-cang-T92078-Ab-1/ GM-Tg-cang-T92078-Ab-2; GM-Tg-bovg-T92078-Ab-1/ GM-Tg-bovg-T92078-Ab-2; GM-Tg-equg-T92078-Ab-1/ GM-Tg-equg-T92078-Ab-2 |
Products Name | Anti-CRMP2/DPYSL2 monoclonal antibody |
Format | mab |
Target Name | CRMP2/DPYSL2 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | Therapeutics Target |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) |
IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-CRMP2/DPYSL2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.